Results 91 to 96 of about 304 (96)
Some of the next articles are maybe not open access.

Visceralna debelost: prijemališče zdravljenja metaboličnega sindroma: target for the manegemant of the metabolic syndrome: Visceral adiposity:

2016
Obesity is linked to increased morbidity and mortality. In addition to body mass index measuring of waist circumfernece is essential for the identification of individuals who are at high risk for metabolic and cardiovascular diseases that are leading causes of mortality in this population.
Janež, Andrej, Jensterle Sever, Mojca
openaire   +1 more source

Leptin in debelost - nevroendokrini, presnovni in aterogeni učinki leptina: Leptin and obesity - neuroendocrine, metabolic and atherogenic effects of leptin:

2003
Background. Leptin is an adipocyte-derived hormone that was recently discovered. Leptin and leptin resistance play an important role in the pathogenesis of obesity. Leptin acts by binding to specific receptors in the hypothalamus to alter the expression of several neuropeptides that regulate food intake and energy expenditure.
Mavri, Alenka, Šabovič, Mišo
openaire   +1 more source

Hormon stradanja fibroblastni rastni dejavnik 21 - novo zdravilo za debelost in metabolni sindrom?: Fasting hormone fibroblast growth factor 21 - new therapy for obesity and metabolic syndrome?:

2009
Increasing prevalence of metabolic diseases is alarming and highlights the need for more effective and safer therapies. Current recommendations for therapy for metabolic syndrome focus on corrections of the individual components. Fibrates are used to treat hyperlipidemia as a predisposing factorto metabolic syndrome and cardiovascular disease. Fibrates
openaire   +1 more source

Home - About - Disclaimer - Privacy